Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 173 drugs
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tabalumab | [1] Tabalumab Tabalumab | [1] Tabalumab
Tabalumab
💬1. Tabalumab
| [1] TNFSF13B TNFSF13B 💬1. Tabalumab
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B ... | [2] 46 46, 49 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Tabelecleucel | [1] Tabelecleucel Tabelecleucel | [1] Tabelecleucel
Tabelecleucel
💬2. Tabelecleucel
| - | - | [1] 65 65 💬2. Tabelecleucel
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Tacrine | [0] | [1] Tacrine
Tacrine
💬3. Tacrine
| [1] ACHE ACHE 💬3. Tacrine
| [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2] 46 46, 271 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Tacrolimus | [2] Prograf Prograf; TACROLIMUS | [2] Tacrolimus
Tacrolimus
,Tacrolimus 💬 4. Tacrolimus
| [5] PPP3CA PPP3CA,PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 [33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell ... | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 16 ... 4. Tacrolimus
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Tadalafil | [4] Adcirca Adcirca; CIALIS; Tadalafil; TADALAFILO | [1] Tadalafil
Tadalafil
💬5. Tadalafil
| [1] PDE5A PDE5A 💬5. Tadalafil
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [7] 6 6, 51, 75, 84, 86, 113, 210 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Tadekinig alfa | [1] TADEKINIG ALFA TADEKINIG ALFA | - | - | - | [1] 65 65 💬6. Tadekinig alfa
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Tafamidis | [2] Tafamidis Tafamidis; Vyndaqel | [1] Tafamidis
Tafamidis
💬7. Tafamidis
| [1] TTR TTR 💬7. Tafamidis
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬7. Tafamidis
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Tafluprost | [1] TAFLUPROST TAFLUPROST | [1] Tafluprost
Tafluprost
💬8. Tafluprost
| [1] PTGFR PTGFR 💬8. Tafluprost
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway 💬 [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pa ... | [1] 299 299 💬8. Tafluprost
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | TAK-475 | [1] TAK-475 TAK-475 | - | - | - | [1] 79 79 💬9. TAK-475
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | TAK-715 | [1] TAK-715 TAK-715 | - | - | - | [1] 46 46 💬10. TAK-715
|